Brief: Anika Therapeutics Q4 Revenue USD 30.602 Million
12/03/2025 20:06
Mar 12 (Reuters) - Anika Therapeutics Q4 net income USD -21.865 million. Q4 pretax profit USD 38 thousand Q4 gross profit USD 17.125 million
ANIK — Anika Therapeutics News Story
0.000.00%
Last trade - 00:00- $191.87m
- $150.85m
- $112.82m